Brought to you by:
SVS executive director elected to executive council of Council of Medical Specialty Societies
The Society for Vascular Surgery (SVS) Executive Director Kenneth M. Slaw, PhD, has been elected to executive council of the Council of Medical Specialty Societies (CMSS). The Council of Medical Specialty Societies (CMSS) is an organization of 53 boarded medical…
Carotid disease: Getting to the right decision
The recent move by the Centers for Medicare & Medicaid Services (CMS) to expand coverage for carotid artery stenting brought with it the requirement for a shared decision-making interaction between physicians and patients as they establish which carotid revascularization treatment…
DETOUR1 and DETOUR2 pooled analysis of bypass system reveals primary rate of 68.1% through 24 months
Endologix has announced results from a pooled analysis of the DETOUR1 and DETOUR2 studies evaluating percutaneous transmural arterial bypass (PTAB) with the Detour system. The Detour system offers a novel approach to treating complex peripheral arterial disease (PAD), enabling physicians to bypass…
PROMISE II 12-month data show durable outcomes with the LimFlow system in no-option CLTI patients
One-year results from the PROMISE II US pivotal trial demonstrate the durability of outcomes of transcatheter arterialisation of the deep veins (TADV) using the LimFlow system (LimFlow) and that the procedure is safe and reproducible. Daniel Clair (Vanderbilt University Medical…
The top 10 most popular Vascular Specialist stories of October 2023
Last month, the most popular stories from Vascular Specialist included The Centers for Medicare & Medicaid Services (CMS) confirmation of carotid artery stenting coverage expansion; data on a “next generation” inferior vena cava (IVC) filter retrieval device presented at the annual…
LimFlow announces agreement to be acquired by Inari Medical
LimFlow announced today that it has entered into a definitive agreement to be acquired by Inari Medical. A press release details that, under the terms of the agreement, LimFlow will receive US$250 million in cash at closing and be eligible…
Computer-assisted vacuum thrombectomy system for patients with pulmonary embolism demonstrates ‘rapid, statistically significant’ improvement in RV/LV ratio
Patients undergoing computer-assisted vacuum thrombectomy with the Indigo Aspiration System (Penumbra) for pulmonary embolism (PE) showed 2.7% rates of both major adverse events (MAEs) and major bleeding at 48 hours post-procedure alongside “a significant reduction” in right ventricle/left ventricle (RV/LV)…
CLTI: European cohort study provides ‘strong positive evidence’ for surgery over endovascular approach, supporting BEST-CLI results
A recently published study has shown that lower limb bypass surgery offered a significantly higher probability of amputation-free survival and wound healing compared with endovascular treatment in patients with chronic limb-threatening ischemia (CLTI). This and other key findings from the…
For Diabetes Month, diabetes resources for SVS members, patients
November is National Diabetes Month. Because SVS members treat patients with the condition—and its complications—the Society has numerous educational resources available. “Diabetes and Vascular Disease” is one of nearly 10 patient education fliers produced by the SVS Foundation as part…
Akura thrombectomy system for PE appears safe and demonstrates reduction of RV/LV ratio in first-in-human study
Results from a first-in-human, prospective, single-arm study of the Akura Medical thrombectomy system (Akura Medical) for pulmonary embolism (PE) were revealed this week at The VEINS 2023 (28–30 October, Las Vegas, USA). Presenter Jay Mathews (Manatee Memorial Hospital, Bradenton, USA)…